Dr. Amoozgar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
327 Lehigh Ave
Perth Amboy, NJ 08861
Summary
- Dr. Behzad Amoozgar, a second-year Hematology-Oncology fellow at the John Theurer Cancer Center, exemplifies a commitment to advancing medical research, education, and patient care. Born in Tehran, Iran, he graduated with high honors from Tehran University of Medical Sciences before embarking on a global career in clinical research and education. He conducted a clinical research fellowship at McMaster University and served as a research scholar at UCSF, where his contributions earned him U.S. permanent residency through the National Interest Waiver pathway. Concurrently, he earned an MPH from UC Berkeley, focusing on Medicaid expansion's impact on lymphoma outcomes. During his residency at Hackensack Meridian Health JFK University Medical Center, Dr. Amoozgar excelled academically, earning the PGY2 Faculty Award and the National ACP Best Clinical Research Award. He later served as an instructor at Washington University in St. Louis, refining his expertise in inpatient oncology care and mentoring trainees. An accomplished clinician-scientist, Dr. Amoozgar’s research spans hematologic malignancies, CAR-T therapy, and lymphoma therapeutics, with a robust portfolio of publications and educational outreach via his YouTube channel, Cancer Therapeutics. Outside of medicine, he enjoys drumming, fitness, and outdoor activities, embodying a balanced and dynamic approach to life and work.
Education & Training
- Hackensack University Medical CenterFellowship, Hematology and Medical Oncology, 2023 - 2026
- University of California, BerkeleyMPH, 2018 - 2021
- JFK Medical Center/Raritan Bay Medical CenterResidency, Internal Medicine, 2018 - 2021
- University of ChicagoExternship, Ophthalmology , 2016 - 2016
- Tehran University of Medical Sciences School of MedicineClass of 2013
Certifications & Licensure
- NY State Medical License 2023 - 2026
- NJ State Medical License 2019 - 2025
- MO State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
- Centennial CollegeMedical Ophthalmic Assistant
- McMaster University Clinical Research Coordinator
- McMaster UniversityHealth Informatic Diploma (in progress)
Publications & Presentations
PubMed
- Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2024-11-14 - Survival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database.Ayrton Bangolo, Behzad Amoozgar, Abhishek Thapa, Wardah Bajwa, Vignesh K Nagesh
Medical Sciences. 2024-10-31 - 18 citationsTafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat
Blood. 2023-12-28
Journal Articles
- Anterior Glenohumeral Dislocation Associated with Simultaneous Fracture of the Lesser and Greater Tuberosities: A Case ReportMohammad Reza Giti, Alireza Mobasseri, Behzad Amoozgar, Injury
- Mesenchymal Stem Cells Injection with Core Decompression in the Treatment of Kienbock diseaseSaeed reza mehrpour, Alireza Mobasseri, Behzad Amoozgar, JOURNAL OF MEDICAL HYPOTHESES AND IDEAS, 2015
Research History
- Volunteer Research-Technician AssistantToronto Western Hospital/Ophthalmology2013 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: